Cookie policy notice

By continuing to use this site you agree to our cookies policy below:
Since 26 May 2011, the law now states that cookies on websites can ony be used with your specific consent. Cookies allow us to ensure that you enjoy the best browsing experience.

This site is intended for health professionals only

At the heart of general practice since 1960

Expert questions NICE advice on PSA testing

By Nigel Praities

A leading NICE advisor has cast doubt on the institute's recommendation that PSA testing should be used for diagnosis of prostate cancer, warning it placed GPs under pressure with little evidence of benefit.

Speaking at Primary Care 2008 in Birmingham, Professor David Weller, head of general practice at the University of Edinburgh and a key advisor to NICE, also said many GPs now faced requests for PSA testing on almost a daily basis – but warned there was scant evidence they reduced mortality. ‘The dilemma with PSA testing is you end up doing a lot of tests and treatment, but mortality rates remain low.'

Rate this article 

Click to rate

  • 1 star out of 5
  • 2 stars out of 5
  • 3 stars out of 5
  • 4 stars out of 5
  • 5 stars out of 5

0 out of 5 stars

Have your say